Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 25349302

Phase III comparison of tamoxifen versus tamoxifen plus ovarian function suppression in premenopausal women with node-negative, hormone receptor-positive breast cancer (E-3193, INT-0142): a trial of the Eastern Cooperative Oncology Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2014 Dec 10
First author
Tevaarwerk AJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2014 Dec 10;32(35):3920-2. doi: 10.1200/JCO.2014.57.9953.
    note
    Source null
    related pmid
    25366692
    relationship
    Comment in

Authors and identifiers

  1. name
    Tevaarwerk AJ
    type
    Author
  2. name
    Wang M
    type
    Author
  3. name
    Zhao F
    type
    Author
  4. name
    Fetting JH
    type
    Author
  5. name
    Cella D
    type
    Author
  6. name
    Wagner LI
    type
    Author
  7. name
    Martino S
    type
    Author
  8. name
    Ingle JN
    type
    Author
  9. name
    Sparano JA
    type
    Author
  10. name
    Solin LJ
    type
    Author
  11. name
    Wood WC
    type
    Author
  12. name
    Robert NJ
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Tevaarwerk AJ
    type
    Author
  2. name
    Wang M
    type
    Author
  3. name
    Zhao F
    type
    Author
  4. name
    Fetting JH
    type
    Author
  5. name
    Cella D
    type
    Author
  6. name
    Wagner LI
    type
    Author
  7. name
    Martino S
    type
    Author
  8. name
    Ingle JN
    type
    Author
  9. name
    Sparano JA
    type
    Author
  10. name
    Solin LJ
    type
    Author
  11. name
    Wood WC
    type
    Author
  12. name
    Robert NJ
    type
    Author
bibliography ids
  1. nci-bib-9a6fead1434fff04e98b6ae7
book metadata
content sha256
fc9736716d712ca5adf1115862e1d29063009c30c646d0fa2bdc148e58ecd3e4
document type
citation
dois
  1. 10.1200/JCO.2014.55.6993
electronic publication date
display
2014 Oct 27
precision
day
year
2014
evidence scope
bibliographic_metadata_only
id
pubmed:25349302
immutable id
pubmed:25349302@fc9736716d712ca5adf1115862e1d29063009c30c646d0fa2bdc148e58ecd3e4
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
35
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
3948-58
volume
32
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2014 Dec 10;32(35):3920-2. doi: 10.1200/JCO.2014.57.9953.
    note
    Source null
    related pmid
    25366692
    relationship
    Comment in
outcomes validated
false
pmid
25349302
provenance
batch id
863b068fe5a07222af6a
provider
NCBI PubMed ESummary
record sha256
e80d98299a1f218d8c04bd697daad126914aaa75cbdeded93e45407354c62998
response sha256
80b1cc99e93fcfceb3e1b12ea433c615b032a2db13a615db7a6e9382c17c5034
retrieved at
2026-09-09T23:47:07.648963+00:00
publication date
display
2014 Dec 10
precision
day
year
2014
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, N.I.H., Extramural
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/25349302/
title
Phase III comparison of tamoxifen versus tamoxifen plus ovarian function suppression in premenopausal women with node-negative, hormone receptor-positive breast cancer (E-3193, INT-0142): a trial of the Eastern Cooperative Oncology Group.

Preserved source evidence · Not medical advice